These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 598046)

  • 41. The influence of age on the behaviour of carcinoma of the breast.
    Devitt JE
    Can Med Assoc J; 1970 Oct; 103(9):923-6. PubMed ID: 5476779
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Recurrence-free interval following radiotherapy or combined surgical-radiological therapy of breast cancer].
    Bünemann H
    Strahlentherapie; 1973 Aug; 146(2):155-65. PubMed ID: 4767145
    [No Abstract]   [Full Text] [Related]  

  • 43. [Oral high-dose medroxyprogesterone acetate (MPA) in the treatment of advanced and recurrent breast cancer: a dose-response evaluation].
    Tominaga T; Izuo M; Nomura Y; Kubo K; Abe O; Enomoto K; Takatani O
    Gan To Kagaku Ryoho; 1982 Nov; 9(11):1994-2004. PubMed ID: 6223590
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combination chemotherapy as an adjuvant treatment in operable breast cancer.
    Bonadonna G; Brusamolino E; Valagussa P; Rossi A; Brugnatelli L; Brambilla C; De Lena M; Tancini G; Bajetta E; Musumeci R; Veronesi U
    N Engl J Med; 1976 Feb; 294(8):405-10. PubMed ID: 1246307
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical control of metastases in patients with advanced cancer of the breast.
    Sellwood RA; Burn I; Fotherby K
    Proc R Soc Med; 1974 Sep; 67(9):854-7. PubMed ID: 4610590
    [No Abstract]   [Full Text] [Related]  

  • 46. Evaluation of radioactive phosphorus in the palliation of metastatic bone lesions from carcinoma of the breast and prostate.
    Cheung A; Driedger AA
    Radiology; 1980 Jan; 134(1):209-12. PubMed ID: 6153129
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Adjuvant chemotherapy in breast cancer: status in 1984].
    Jungi WF
    Wien Klin Wochenschr; 1984 Jun; 96(13):486-92. PubMed ID: 6382805
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adjuvant systemic therapy in primary breast cancer.
    Mouridsen HT; Palshof T
    Acta Chir Scand Suppl; 1984; 519():43-53. PubMed ID: 6393664
    [No Abstract]   [Full Text] [Related]  

  • 49. [ACF combination consisting of adriamycin, cyclophosphamide and oral futraful for recurrent advanced breast cancer (author's transl)].
    Murosaki S; Inagaki J; Horikoshi N; Esaki K; Inoue K; Nagura E; Ueoka H; Takano Y; Kobayashi T; Okabe K; Ogawa M
    Nihon Gan Chiryo Gakkai Shi; 1981 Feb; 16(1):8-14. PubMed ID: 6790641
    [No Abstract]   [Full Text] [Related]  

  • 50. [Antiestrogens in the treatment of breast cancer].
    Gnatyshak AI
    Vopr Onkol; 1981; 27(9):43-7. PubMed ID: 7027619
    [No Abstract]   [Full Text] [Related]  

  • 51. [Survival kinetics of breast cancer patients undergoing combined chemotherapy for recurrences and metastases].
    Korman DB; Maslova IA; Borisov AI
    Vopr Onkol; 1982; 28(8):14-9. PubMed ID: 7113064
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of sex hormones on peripheral immunity in patients with advanced breast cancer.
    Franks CR; Williams Y
    Clin Oncol; 1978 Mar; 4(1):19-24. PubMed ID: 639376
    [No Abstract]   [Full Text] [Related]  

  • 53. [Tamoxifen therapy in locally advanced primary and recurrent breast cancer (author's transl)].
    Wada T; Koyama H; Takahashi Y; Nishizawa Y; Iwanaga T; Aoki Y; Terasawa T
    Nihon Gan Chiryo Gakkai Shi; 1979 Aug; 14(5):819-24. PubMed ID: 501187
    [No Abstract]   [Full Text] [Related]  

  • 54. [Hormone therapy of neoplasms].
    Abe K
    Nihon Naika Gakkai Zasshi; 1991 Mar; 80(3):373-6. PubMed ID: 1649883
    [No Abstract]   [Full Text] [Related]  

  • 55. Duration of anti-HER2 blockage therapy may improve survival in HER2 positive metastatic breast carcinoma patients.
    Arslan UY; Turker I; Aksoy S; Oksuzoglu B; Helvaci K; Yildirim Ozdemir N; Uyeturk U; Uysal Sonmez O; Budakoglu B; Zengin N
    J BUON; 2013; 18(3):585-93. PubMed ID: 24065468
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aminoglutethimide in the treatment of advanced postmenopausal breast cancer.
    Harris AL; Powles TJ; Smith IE
    Cancer Res; 1982 Aug; 42(8 Suppl):3405s-3408s. PubMed ID: 7083207
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The mammography--a criterion in hormonal by treated mastopathy].
    Kleibel F
    Strahlentherapie; 1970 Jul; 140(1):128-31. PubMed ID: 5486787
    [No Abstract]   [Full Text] [Related]  

  • 58. COMPARISON OF 6-ALPHA-METHYL-9-ALPHA-FLUORO-17-ACETOXY-21-DEOXYPREDNISOLONE WITH FLUOXYMESTERONE AND METHYLPREDNISOLONE IN TREATMENT OF METASTATIC BREAST CANCER.
    TALLEY RW; BRENNAN MJ; VAITKEVICIUS VK; SANDIEGO EL; REED ML; LEIGHTON GA
    Cancer; 1964 Aug; 17():1063-6. PubMed ID: 14202593
    [No Abstract]   [Full Text] [Related]  

  • 59. Fluoxymesterone in the treatment of advanced breast cancer.
    KENNEDY BJ
    Cancer; 1957; 10(4):813-8. PubMed ID: 13472624
    [No Abstract]   [Full Text] [Related]  

  • 60. Comparison of 2,17-dimethyl testosterone and fluoxymesterone in metastatic breast cancer. Nonprogression--an index of tumor therapy evaluation.
    TALLEY RW; BRENNAN MJ; VAITKEVICIUS VK; BECKETT VL
    Cancer; 1963 Apr; 16():440-3. PubMed ID: 13984784
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.